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We have studied the glucuronidation of the thyroid hormones T4, T, and rT, by liver microsomes of Wistar, Gunn and WAG rats. Gunn rats have 
a defect in the gene coding for bilirubin and phenol UDP-glucuronyltransferase (UGT) isoenzymes; WAG rats have a genetic defect in androsterone 
UGT. In normal Wistar rats UGT activity was &fold higher for rT> than for T, or T,. UGT activities for T4 and rT,, but not for T,, were impaired 
in Gunn rats. Conversely, UGT activity for T,, but not for T, or rT,, was impaired in WAG rats. Thus, in rat liver rT, is glucuronidated much 
more rapidly than T, and T,. Our results support the view that T, and rT, are glucuronidated by bilirubin and phenol UGTs and T, by androsterone 
UGT. 
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1. INTRODUCTION 
Deiodination and conjugation are the principal meta- 
bolic pathways for thyroid hormone [l-3]. Thyroxine 
(3,3’,5,5’-tetraiodothyronine, TJ is the main secretory 
product of the thyroid, but has little biological activity. 
The most active form of thyroid hormone, 3,3’,5-triio- 
dothyronine (T3), is largely produced by outer ring 
deiodination of T, in peripheral tissues. Conversely, if 
T, is deiodinated in the inner ring, the inactive metabo- 
lite 3,3’,5’-triiodothyronine (reverse T,, rT3) is pro- 
duced. The type I iodothyronine deiodinase in liver and 
kidney plays an important role in the peripheral conver- 
sion of T4 to T, but is much more active in the deiodina- 
tion of rT, [1,2]. 
glucuronidation of T4 by these enzymes is correct, UGT 
activity for Tq, but not for T,, should be impaired in 
Gunn rats. Also, to our knowledge rT, has never been 
tested as a substrate for microsomal UGT activity. We 
have, therefore, compared microsomal UGT activities 
for T4, T3 and rT3 in untreated Wistar, Gunn and WAG 
rats. 
2. MATERIALS AND METHODS 
2.1. Tissue preparations 
Hepatic T, glucuronidation is induced by treatment 
of rats with various substances, which has led to the 
hypothesis that T, is a substrate for at least two isoen- 
zymes, i.e. 3-methylcholanthrene (MC)-inducible phe- 
nol UGT and clofibrate-inducible bilirubin UGT [4,5]. 
Glucuronidation of T, shows little response to these 
treatments. However, T, glucuronidation is impaired in 
Wistar LA, Fischer and WAG rats, all of which have 
a defect in androsterone UGT, while T, conjugation in 
these rats is virtually normal [4-61. Gunn rats have a 
defect in the gene coding for multiple phenol and biliru- 
bin UGT isoenzymes [7,8]. If our hypothesis about the 
Male rats weighing 15&200 g were used in all studies. Wistar and 
Gunn rats were obtained from Harlan Sprague-Dawley (Zeist, The 
Netherlands), and WAGIRIJ-MBL (WAG) rats were raised at TN0 
Medical Biological Laboratory (Rijswijk, The Netherlands). Animals 
were decapitated under ether anesthesia; the livers were rapidly iso- 
lated and stored at -80°C until further processing. For preparation 
of microsomes, tissues were homogenized on ice in 4 volumes 10 mM 
HEPES (pH 7.0), 0.25 M sucrose and 1 mM DTT. The homogenates 
were centrifuged for 10 min at 4°C and 25,000 x g, and the supema- 
tants for 60 min at 100,000 x g. The microsomal pellets were dispersed 
in 0.1 M phosphate (pH 7.2), 2 mM EDTA and 1 mM DTT at a 
protein concentration of 10-20 mg/ml, and stored in aliquots at -80°C 
until further analysis. Protein content was determined with the BCA 
protein assay reagent (Pierce, Oud Beijerland, The Netherlands) using 
BSA as the standard. 
2.2. Iodothyronine UGT assay 
Correspondence address: T.J. Visser, Department of Internal Medicine 
III, Erasmus University Medical School, PO Box 1738, 3000 DR 
Rotterdam, The Netherlands. Fax: (31) (10) 463 5430. 
[3’,5’-‘Z51]T,, [3’-“‘I]Tj and [3’,5’-‘*‘I]rTg were obtained from Amer- 
sham (Amersham, UK). While [‘ZSI]Tg could be used without purifica- 
tion, labeled T4 and rT, were purified before each assay on Sephadex 
LH-20 [4]. Nonradioactive T, and T, were obtained from Sigma (St. 
Louis, MO, USA) and rT, from Henning GmbH (Berlin, FRG). 
Iodothyronine UGT assay mixtures usually contained 1 PM T,, T, or 
rT,, =O.l PCi of the ‘Z51-labeled substrate, 1 mg microsomal protein/ 
Published by Elsevier Science Publishers B. V. 65 
Volume 315, number 1 FEBSLETT’ERS January 1993 
0 30 60 90 120 150 0.0 0.5 1.0 1.5 2.0 2.5 
TIME (min) PROTEIN (mg/ml) 
50 b 
‘ - 
O)J 
Fig. 1. Iodothyronine glucuronidation by Wistar HA rat liver microsomes. OnepM T4, T, or rT, were incubated in triplicate at 37“C during 15-120 
min with 1 mg microsomal protein/ml (A) or during 60 min with 0.2552 mg microsomal protein/ml (B). 
ml, 1 mM propylthiouracil (PTU; Sigma), 5 mM UDP-glucuronic acid 
(UDPGA; Boehringer Mannheim. Almere, The Netherlands), 75 mM 
Tris-HCl (pH 7.8) and 7.5 mM MgCl,, with a final volume of 200 ,ul. 
PTU was added to inhibit deiodination [1] without affecting the glucu- 
ronidation of the different iodothyronines. Incubations were done in 
triplicate for 1 h at 37C, and controls were incubated in the absence 
of UDPGA. Reactions were terminated by addition of an equal vol- 
ume of ice-cold methanol. After centrifugation, supematants were 
analyzed for glucuronide formation on Sephadex LH-20 [4]. 
2.3. Other UGT assays 
PNP UGT activity was assayed by reaction of 1 mM PNP for 15 
min at 37°C with 0.25 mg microsomal protein/ml and 5 mM UDPGA 
in 100 mM Tris-HCl (pH 7.4). 5 mM MgCl, and 0.005% Brij 58 [4,9]. 
Androsterone UGT activity was assayed by reaction of 100 PM an- 
drosterone for 15 min at 37°C with 0.5 mg microsomal protein/ml and 
5 mM UDPGA in 100 mM Tris-HCl (pH 7.4), 3.75 mM MgCl, and 
0.005% Brij 56. [4,10]. Bilirubin UGT activity was assayed using a 
modification of the method of Heirwegh et al. [1 1] by reaction of 100 
PM bilirubin for 15 min at 37°C with 1 mg microsomal protein/ml and 
5 mM UDPGA in 100 mM Tris-HCl (pH 7.8) 3.75 mM MgCl,, 
0.125% BSA and 0.025% CHAPS. 
3. RESULTS 
Determination of the androsterone UGT activity in 
the liver microsomes of the 6 Wistar rats tested showed 
that 4 animals had the high-activity (HA) and 2 the 
low-activity (LA) phenotype, glucuronidation rates in 
the latter being only 7% of those in the former. Table 
I presents the UGT activities for androsterone, PNP 
and bilirubin in the Wistar, WAG and Gunn rats. The 
mean androsterone UGT activity in the WAG rats is 
only 5% of that in Wistar HA rats and, thus, very sim- 
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ilar to that in the Wistar LA rats. Androsterone glucu- 
ronidation rates were similar in Wistar HA and Gunn 
rats. Conversely, bilirubin glucuronidation was unde- 
tectable and PNP glucuronidation was strongly im- 
paired in Gunn rats, while these UGT activities were 
similar in Wistar and WAG rats. 
Fig. 1 shows the glucuronidation of T4, T3 and rT, by 
liver microsomes of Wistar HA rats as a function of the 
microsomal protein concentration and incubation time. 
The results indicate that the glucuronidation of T4 and 
T, was roughly linear with time up to 2 h, while rT, 
glucuronide increased linear with time only during the 
first 30 min due to substrate depletion upon prolonged 
Table I 
Hepatic phenol, androsterone and bilirubin UGT activities in Wistar, 
Gunn and WAG rats. 
Rats UGT activity 
PNP Androsterone Billirubin 
Wistar 
WAG 
Gunn 
81.2 + 9.6 6.13 f 0.53” 0.77 f 0.21 
106.9 f 18.6 0.29 + 0.03” NT” 
26.6 f 6.6b 7.07 f 0.26 0.00 f O.OOb 
Results are expressed as nmol/min/mg protein and presented as 
means -+ S.D. of 4-8 determinations. “) Data represent values for 4 
Wistar HA rats; androsterone UGT activity in 2 Wistar LA rats was 
0.43 and 0.44 nmol/min/mg protein. b, Significant decrease compared 
with Wistar rats (P < 0.001). ‘) Not tested. 
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Fig. 2. Iodothyronine UGT activities in liver microsomes from Wistar 
HA, WAG and Gunn rats. One PM T4, T, or rTf were incubated in 
triplicate for 60 min at 37°C with 1 mg microsomal protein/ml. Results 
are presented as mean f S.D. of 4-6 determinations. *Significant de- 
crease compared with Wistar HA rats (P < 0.001). Note the difference 
in scales for UGT activities for T, and T, (kfi) and for rT3 (right). 
incubation. Although the glucuronidations of Tq, T, 
and rT, were clearly dependent on the amount of micro- 
somes added, the increases deviated from linearity at 
low protein concentration. It is clear, however, that at 
any incubation time or protein concentration glucu- 
ronide formation was similar with T4 and T,, while rT3 
glucuronidation was = 5 times more rapid. 
Fig. 2 shows the hepatic UGT activities for T,, T, and 
rT, in Wistar HA, WAG and Gunn rats determined in 
standard 1 h incubations with 1 mg microsomal protein/ 
ml. Compared with Wistar HA rats, glucuronidation of 
T, was on average decreased by 28%, of T, by 67%, and 
of I-T, by 12% in the 2 Wistar LA rats (not shown). 
Mean UGT activities in WAG rats were 16% higher for 
Tq, 54% lower for T,, and 66% higher for rT, than in 
Wistar HA rats. Mean glucuronidation rates in Gunn 
rats were 43% lower for T4, 8% higher for T3, and 74% 
lower for rT, in comparison with Wistar HA rats. 
4. DISCUSSION 
The glucuronidation of a variety of endogenous and 
exogenous compounds is catalyzed by a family of ho- 
mologous UGT isoenzymes, which are located in the 
endoplasmic reticulum of liver as well as other tissues 
[12,13]. The purpose of this conjugation reaction is to 
increase the water-solubilty of the substrates and, thus, 
to expedite their excretion in the bile or the urine. In 
general, UGTs are high-K,, high-capacity enzymes with 
broad and overlapping substrate specificities. The activ- 
ities of some of these isoenzymes show specific re- 
sponses to treatment of rats with microsomal enzyme 
inducers. For instance, clofibrate induces UGT activity 
for bilirubin but not for PNP, whereas MC induces 
UGT activity for PNP but not for bilirubin [12]. 
Recently, the structures of a number of UGTs have 
been characterized, among others those which glucu- 
ronidate phenols or bilirubin [I 3,141. This has led to the 
recognition of the UGTl subfamily in both rats and 
humans, which is comprised of multiple bilirubin and 
phenol UGT isoenzymes encoded by a single gene 
[8,13-l 51. Through alternative splicing of the primary 
transcript, different mRNAs are produced, each of 
which combine a constant domain with a variable do- 
main. These appear to code for the C-terminal 
UDPGA-binding domain and the N-terminal substrate- 
binding domain of the protein, respectively [8,13-l 51. It 
has been demonstrated that Gunn rats have a -1 fra- 
meshift deletion in the common domain of the UGTl 
gene, with a resultant failure in the expression of all 
members of this subfamily [7,8]. These rats, therefore, 
lack bilirubin and MC-inducible PNP UGT activities. 
The defective expression of androsterone UGT activity 
in Wistar LA rats has recently been found to be due to 
the deletion of a major portion of the gene [ 16,171. This 
is probably also the case in WAG and Fischer rats, 
which are also deficient in androsterone UGT activity 
]5,6,181. 
Previous observations have suggested that different 
UGT isoenzymes are involved with the glucuronidation 
of thyroid hormone. Thus, glucuronidation of T4 in 
liver is stimulated by treatment of rats with different 
classes of microsomal enzyme inducers, such as (i) MC- 
type inducers, including PCBs, dioxin, /3naphtoflavone 
and hexachlorobenzene [4,6,19-281, (ii) phenobarbital 
[2429], (iii) the phenoxyisobutyrate derivatives clofi- 
brate, ciprofibrate and nafenopine [5,30,31], (iv) pregne- 
nolone-16a-carbonitrile [25,27,28], and (v) spironolac- 
tone [32]. In general, the effects of such treatments on 
T4 UGT activity are much greater than on T, glucu- 
ronidation, while studies of hepatic rT, UGT activity 
have not been reported . 
Previous findings have indicated that rat strains with 
a genetic defect in androsterone UGT expression also 
show impaired T, UGT activity, while T4 glucuronida- 
tion is not or only little affected [4-61. A recent study 
has reported on a decrease in T, UGT activity in Gunn 
rats, but glucuronidation of T, and rT, was not ana- 
lyzed [28]. We have now shown using liver microsomes 
of normal Wistar rats that glucuronidation rates are 
= S-fold higher with rT, than with T4 or T3 as substrate. 
In contrast to the marked impairment of T3 UGT activ- 
ity in WAG rats, glucuronidation of T4 and rT, was not 
affected. Conversely, UGT activities for T4 and espe- 
cially rT, were markedly impaired in Gunn rats, 
whereas T3 glucuronidation was normal. 
Our results are compatible with the hypothesis that 
T4 is conjugated by both MC-inducible phenol UGT 
67 
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and fibrate-inducible bilirubin UGT [4,5]. Relative to 
Tqr however, rT, is by far the preferred substrate for 
these isoenzymes. These conclusions are supported by 
recent findings that T, and, even more so, rT, are glucu- 
ronidated by human phenol and bilirubin UGT clones, 
stably expressed in cell culture (manuscript in prepara- 
tion). Androsterone UGT appears to be an important 
isoenzyme for the glucuronidation of T3. However, the 
incomplete defects in the glucuronidation of T4 and rT, 
in Gunn rats and that of T, in WAG rats suggest he 
involvement of additional UGT isoenzymes. It is re- 
markable that among the different iodothyronines rT, 
is most rapidly metabolized by both deiodination and 
glucuronidation. The importance of this for the regula- 
tion of thyroid hormone bioactivity remains to be fully 
understood. 
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